Class B G protein-coupled receptors (GPCRs) are involved in a variety of human pathophysiological states. These groups of membrane receptors are less studied than class A GPCRs due to the lack of structural information, delayed small molecule drug discovery, and scarce fluorescence detection tools available. The class B corticotropin-releasing hormone type 1 receptor (CRHR1) is a key player in the stress response whose dysregulation is critically involved in stress-related disorders: psychiatric conditions (i.e. depression, anxiety, and addictions), neuroendocrinological alterations, and neurodegenerative diseases. Here, we present a strategy to label GPCRs with a small fluorescent antagonist that permits the observation of the receptor in live cells through stochastic optical reconstruction microscopy (STORM) with 23 nm resolution. The marker, an aza-BODIPY derivative, was designed based on computational docking studies, then synthesized, and finally tested in biological cells.
Introduction
Corticotropin-releasing hormone type 1 receptor (CRHR1) belongs to the class B family of G-protein-coupled receptors (GPCRs). 1 GPCRs are the largest group of membrane proteins, and they are targets for about one third of pharmaceutical agents. 2 Structural studies of transmembrane domains (TMDs), which couple GPCR activation to signaling effectors, have been delayed for class B members in relation to class A GPCRs. CRHR1 and the glucagon receptor were the first two class B whose TMD crystal structures were solved. 3, 4 The corticotropin-releasing hormone (CRH) is a 41-aa peptide ligand for CRHR1, crucial in the integration of neuroendocrine, autonomic, and behavioral responses to stress. 5 CRH-activated CRHR1 triggers a variety of cellular responses, leading to cAMP increase and activation of multiple signaling cascades. 6 Dysregulation of the CRH/CRHR1 responses in the central nervous system is related to mood disorders such as anxiety and depression, 7 psychiatric conditions that affect about 15% of the population. 8 Knowledge of the subcellular spatial distribution and pathways of CRHR1 in a neuronal cell context appears to be key for the understanding of its pathophysiological action. 9 Fluorescence nanoscopy is becoming the preferred visualization tool to decipher subcellular protein structures, interactions and pathways. [10] [11] [12] This technique relies on switching the fluorescent probes between an emissive and one or more non-emissive states. This gives special relevance to the photophysical properties of the fluorophores, 13 whose brightness, contrast, photostability and switching performance determine the achievable spatial resolution. 14 A remarkable recent advance has brought this limit to 1 nm, 15 practically the size of the fluorophore. Ultimately, the achievable resolution of nanoscopy methods is limited by the physical size of the fluorescent label.
Various fluorescent labeling strategies are available to study biomolecules: 16, 17 the production of fusion proteins, 18 labeling by post translational modification, 19, 20 or the design of a fluorescent ligand for a specific protein. 21 Targeting a particular protein with a small molecule is the most challenging approach because it requires specific design and synthesis, but it has a number of advantages: (i) it avoids transfection, which allows its direct use in living cells and studies under endogenous cellular protein expression conditions; (ii) it enables the application of fluorescence nanoscopy in its full potential; and (iii) it provides more reliable information about proteinprotein interactions.
While different fluorescent labeling approaches have been proposed and carried out for GPCRs, [22] [23] [24] [25] tagging the antagonist site with small probes appears to be an interesting alternative. 22, 23, 26 In the past few years, small molecule targeting of GPCRs with photoswitchable ligands to remotely control receptor activation has been reported. [27] [28] [29] [30] Specifically for CRHR1, there are a variety of high affinity synthetic non-fluorescent antagonists that modulate CRH effects. 8, [31] [32] [33] One of them, CP-376395, was crystallized with CRHR1. 3 All these facts encouraged us to design a fluorescent probe for super-resolution fluorescence microscopy that would bind to the antagonist site of CRHR1. Fig. 1 summarizes the strategy of this work. First, the structural analysis of effective synthetic antagonists was used to propose fluorescent structures that were analyzed by docking studies. The chosen candidate proved very effective as a CRHR1 antagonist and showed excellent features for fluorescence nanoscopy. The fluorophore was used together with fluorescent immunolabeling of CRHR1 to estimate the binding equilibrium constant in neuronal cells by two color stochastic optical reconstruction microscopy (STORM).
Results and discussion
Design and synthesis of ABP-09
We selected an aza-BODIPY scaffold as the basis for the fluorescent marker due to the well described fluorescent features of this type of compound, the versatility of the spectral and photochemical properties, which can be modulated by substitution, and their photochemical stability. 34, 35 We performed in silico docking onto CRHR1 (PDB: 4K5Y) of structures ABP-01 to ABP-11 (see Table S1 , ESI †), and compared the results to the co-crystallized ligand CP-376395 and to ligand ONO-2333Ms 31 as controls. It was implemented with a flexible-ligand-rigid-receptor approach in the ICM software. 36, 37 Evident docking difficulty prevents pluriaromatic substitution in ABPs. This is a strong constraint for aza-BODIPY synthetic feasibility (see below).
Computational chemistry results, combined with photochemical stability criteria, showed that ABP-09 was the best candidate among the proposed structures to act as a stable antagonist for CRHR1, as we explain in what follows. The lowest-energy pose of CP-376395 exhibited a RMSD of 0.4 Å compared to the crystal structure, while the ONO-2333Ms pose showed a consistent overlap with it ( Fig. S9 , ESI †). These two ligands, as well as all the proposed ABP structure, through their central nitrogen, establish a key H-bond with N283 5.50 (Wootten numbering shown in superscript 38 ). Due to the approximations involved, docking scores may correlate poorly with binding affinities, 39,40 so a simple energy rescoring was performed, using a flexible-ligand-flexible-receptor methodology, similar to the ligand-steered approach, [41] [42] [43] but replacing the stochastic sampling by a faster local energy minimization. We omitted the entropic component of the free energy, since only a semi-quantitative estimation of the binding free energy is sought. According to this approach, the binding free energy trend is:
CP-376395 o ONO-2333Ms B ABP-09 B ABP-11 B ABP-10. Considering the chemical stability provided by the methyl substituents in positions 3 and 5 (Table S1, ESI †), we chose ABP-09 as the antagonist candidate, among the three best ABP structures. Fig. 2 compares the docking of CP-376395 and ABP-09. In ABP-09, the 2,4-dichlorophenyl group occupies the same region as the 2,4,6-trimethylphenyl group of CP-376395.
The synthetic route for ABP-09 is depicted in Fig. 3 . The pathway was designed taking advantage of the intrinsically asymmetric reaction mechanism 44, 45 and avoiding the isolation of an unstable a-nitroso pyrrole intermediate.
As almost all aza-BODIPYs described are tetra aryl substituted, 44, 46 the synthesis of ABP-09 posed a challenge. The overall yield of ABP-09 is less than 1% starting from compound 2, but upon isolation, this new compound was thermally and photochemically stable.
Spectroscopic properties of ABP-09
The absorption coefficient, e 530 = (70 AE 10) 10 3 M À1 cm À1 , was derived by comparison to those of BODIPYs and aza-BODIPYs of similar structure and energy. [47] [48] [49] [50] ABP-09 displays a moderate negative solvatochromism. The energies of the maximum absorption and emission wavelengths as well as the Stokes shift show a linear dependence with the E T (30) solvent parameter, as displayed in Fig. S10 (ESI †). Absorption and emission maxima are located at 535 and 552 nm in toluene, at 529 and 550 nm in dichloromethane (see Fig. 4A ), at 517 and 544 in acetonitrile, and at 518 and 546 nm in methanol, respectively ( Fig. S10 , ESI †). Most BODIPY compounds show a very mild positive solvatochromism that is greatly enhanced when electron donating and withdrawing substituents are present. 51 Interestingly, a recent work reported the negative solvatochromism of a group of push-pull aza-BODIPYs with the same substitution pattern in both indole rings. 52 The magnitude of the solvatochromic shift in absorption between toluene and acetonitrile is similar to that of ABP-09, a compound that has moderate electron attracting and donating groups in only one ring.
The red shift (435 nm) in the maximum absorption wavelength of ABP-09 as compared to that of the 1,3,5,7-methyl substituted BODIPY 53 is a consequence of the aza-BODIPY structure. Indeed, such a red-shifted absorbance cannot be explained in terms of an extended conjugation introduced by the 2,4-dichlorophenyl substituent in position 1. This statement is based on the electron withdrawing properties of the chlorine atoms present in the substituent and the low impact of substituents in position 1 on bathochromic shifts. 51, 53, 54 Taken together, these considerations support the point that the observed red shift is a consequence of the effect of the N atom at the meso position. 51, 55 The emission in dichloromethane has a quantum yield of 0.86 AE 0.04 and a lifetime of 3.84 AE 0.01 ns (l exc = 490 nm, Fig. 4B ).
ABP-09 and CP-376395 effect on CRH-activated CRHR1 signaling
The influence of ABP-09 and the CRHR1 antagonist CP-376395 on signaling effectors downstream CRH-activated CRHR1 was tested in HT22-CRHR1 and in HT22-CRHR1-Epac-S H187 cells, stably expressing CRHR1 and both CRHR1 and the FRET-based biosensor for cAMP Epac-S H187 , respectively (see Materials and methods and ESI †). 56 First, using HT22-CRHR1-Epac-S H187 cells, 10 nM CRH stimulation triggered a rapid and sustained cAMP response ( Fig. 5 ) as previously reported. 56 In cells preincubated with either ABP-09 or the antagonist CP-376395 in 10 or 100 nM concentration, cAMP levels decreased similarly compared to control conditions (Fig. 5 ). The preincubation used before stimulation was 20 h, the time after which ABP-09 concentration in living cells attains a level independent of the initial dose that remains constant in time (see Materials and methods and Fig. S12 , ESI †). For both species, the 50% decrease in the FRET response demonstrates an inhibiting effect in this CRHR1 signaling pathway with comparable effectiveness for ABP-09 and CP-376395, showing a saturation effect at 10 nM concentration.
Further evidence of ABP-09 antagonist action was obtained from the analysis of the activation (phosphorylation) of signaling proteins downstream stimulated CRHR1. Cells were also preincubated for 20 h with ABP-09 in these experiments. Two phosphoprotein levels were assessed by western blot in HT22-CRHR1 cells stimulated with 100 nM CRH: pERK1/2, monitored 5 minutes after stimulation, and pAkt, monitored 30 minutes after stimulation. 57 Whereas no changes were observed in basal phosphoprotein levels, when either 100 nM or 1 mM ABP-09 was present, there was a decrease to 75% of the maximum response in pERK1/2 after 5 minutes of stimulation. A decrease in pAkt was evidenced 30 minutes after stimulation in cells treated with the mentioned concentrations of ABP-09 (about 90-70% of the maximum pAkt response, Fig. S13 , ESI †).
ABP-09 as a fluorescent probe for in vivo CRHR1 labeling and STORM imaging
The performance of ABP-09 was benchmarked against Alexa Fluor 647, one of the best-performing fluorophores for STORM. Two-color STORM imaging was performed on the HT22-CRHR1 cell line, which expresses CRHR1 with a cMyc tag at the N-terminus (cMyc-CRHR1). Cells were treated with 10 nM ABP-09 for 20 h, fixed, and the cMyc tag was detected by indirect immunofluorescence using a specific anti-cMyc primary antibody and a secondary antibody labeled with Alexa Fluor 647 ( Fig. 6 ). The localization precision of single molecule localization depends on the width of the point spread function (PSF) of the microscope, the pixel size of the detector, the number of photons collected per event, and the background noise. 58 High photon counts per frame favour location precision, while a low fraction of time in the on state allows location of the molecule in the presence of others as well as an increase in location speed. 59 Consequently, the brightness and blinking performance of ABP-09 was measured in comparison to Alexa Fluor 647. ABP-09 molecules show an average ON time of 33 ms compared to 35 ms for Alexa Fluor 647 (30 ms exposure time), while the ratio between photons emitted by 
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Alexa Fluor 647 and ABP-09 molecules is 2.5 AE 0.5, both under an incident laser excitation of (6 AE 1) kW cm À2 (see Fig. S11 , ESI †). The photostability of ABP-09 is also comparable to that of Alexa Fluor 647. The images have a lateral localization precision of 26 AE 7 nm for Alexa Fluor 647 and 23 AE 7 nm for ABP-09 ( Fig. 6C ). These results demonstrate the excellent features of ABP-09 as a probe for STORM. The slightly lower localization precision for Alexa Fluor 647 compared to that of ABP-09 in spite of the higher brightness of the former probe is attributed to two factors. The first one is the higher background observed in the Alexa Fluor 647 emission channel (Fig. S11, ESI †) . The second one is the size (B10 nm) of the multiple fluorophore labelling of the secondary antibody. Instead, ABP-09 provides a true single molecule label to each receptor. The lower brightness of ABP-09 compared to that of Alexa Fluor 647 is explained by the lower absorption coefficient at the excitation wavelength: 7 Â 10 4 M À1 cm À1 and 2.4 Â 10 5 M À1 cm À1 , respectively. This brightness and stability place ABP-09 among the best performing dyes for single molecule localization in the green light excitation range. 59 
Analysis of the molecular association between CRHR1 and ABP-09
Several methods have been reported to extract quantitative information of molecular association from fluorescence nanoscopy images, such as cluster distribution, pair correlation function, or point patterns, to statistically estimate the significance in approach beyond the statistical random crowding. [60] [61] [62] [63] [64] [65] [66] Here, we obtain an approximation to thermodynamic association equilibrium constants, by computing association coefficients Q ij = N ij /(N i ÁN j ), based on direct counting single and paired molecules (i, j representing either of the fluorophores). A comparison with simulated random distributions provides the reference and calibration of the method (see ESI † for detailed description). Fig. 7B shows that the actual distributions, where HT22-CRHR1 cells were incubated for 20 h with 10 nM ABP-09, computed in different areas of various cells, always present greater association 
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Phys. Chem. Chem. Phys., 2018, 20, 29212--29220 | 29217 than that expected for random pairing. This result is in line with the ABP-09 antagonistic effect on CRHR1 signaling. The effect of adding for 15 minutes the non-fluorescent CRHR1 antagonist CP-376395 in a large excess (10 and 100 mM) to HT22-CRHR1 cells incubated with 10 nM ABP-09 is also shown in Fig. 7B . These last two curves match to a large extent and exhibit a lower fraction of ABP-09/CRHR1 association events when compared to cells untreated with CP-376395. This observation confirms a displacement of ABP-09 from CRHR1 by the dark antagonist. Additionally, the indistinguishable behavior observed for the 10 and 100 mM CP-376395 treatments suggests that a complete displacement is achieved with the lower concentration tested. Fig. 7C includes the analysis of the neighborhood between ABP-09 and CRHR1 in HT22 cells (not expressing cMyc-CRHR1) and compares it with the displacement experiments described for Fig. 7B . The association observed in HT22 cells reflects both random pairing and unspecific binding of labeled antibodies and ABP-09. In both situations (HT22 cells and displacement experiments), the fraction of associated molecules was very similar and significantly lower than the one calculated from the experiments where HT22-CRHR1 cells were incubated with ABP-09 alone. This fact suggests that CP-376395 and ABP-09 are competitors in the association with CRHR1, and that, after displacement, the residual association observed is due to random pairing and unspecific binding. We should note that Q ab includes pairs not only originating from molecular affinity but also others due to random neighborhoods. The images show that ABP-09 and Alexa Fluor 647 also appear as self-associated ( Fig. 6) . Therefore, we also considered the corresponding association constants to describe the molecular distribution of the whole system (see Fig. S14 for Q aa and Q bb , ESI †). The relation between Q ij and their corresponding K ij was explored by simulations of molecular distributions with different values of K ab , K aa , and K bb as a function of molecular density. In these simulations, Q ij was computed and normalized to the corresponding random distribution (Q ij,rndm , all K ij = 0) with the same density, characterized by the parameter R ab = log(Q ab /Q ab,rndm ). The results show that R ab is constant to within AE0.3 logarithmic units as a function of molecular density in a broad range of molecular density (Fig. S15, ESI †) , providing a good calibration criterion.
From the experimental data of Fig. 7 , we obtain R ab = 0.31 AE 0.11 (data of Fig. 7 shown as logarithmic ratio in Fig. S17, ESI †) . Assuming that K aa = K bb , due to the similar values of Q aa and Q bb (Fig. S14, ESI †) , we obtain log K ab = À4.1 AE 0.2, and log K aa = log K ab = À3.2 AE 0.2. An observation volume of 1.35 Â 10 9 nm 3 was calculated considering the 200 Â 200 pixels of 13 Â 13 nm 2 area used as standard and an estimated TIRF irradiation depth of 200 nm. With it, K ab = 8 Â 10 4 M À1 and K aa = K bb = 5 Â 10 5 M À1 are obtained. We will focus here on K ab , as it represents the association between ABP-09 and CRHR1.
The dissociation constant of the ABP-09-CRHR1 complex (the inverse of K ab ) has a value of 12 mM. This value is around three orders of magnitude greater than those of potent CRHR1 antagonists. 31, 32 Nevertheless, inhibition experiments demonstrated that ABP-09 and CP-376395 exert similar inhibiting cellular effects in the same nM bulk concentration range. The association constant that we present was obtained in a cell environment, where local concentration is higher than the average value of the concentration provided. More precisely, the average molecular density of around 0.1 molecules per pixel (the volume corresponding to a pixel is 13 Â 13 Â 200 nm 3 ) is equivalent to a concentration of 5 mM. It represents a 500-fold concentration increase compared to the 10 nM ABP-09 concentration added to the cell preparation to perform the experiments. Therefore, we can predict that the dissociation equilibrium constant of ABP-09-CRHR1 in bulk experiments would also lie in the nM range, similar to most potent known antagonists.
With reference to the value of the dissociation constant, some observations deserve consideration. In the first place, this estimation does not exclude from the analysis the possible unspecific binding of ABP-09 directly to the labeled antibody. Experiments on HT22 cells could be an estimation of this fact, but this is not the only possible interpretation of these results (see below). Secondly, it considers each isolated ABP-09 and the labeled antibody as free molecules, while they could also be associated to different cell components. Thus, these phenomena may result in an overestimation not only of molecular pairing, but also of the total number of free ABP-09 and/or CRHR1. Both effects tend to compensate.
A further concern regards the coincidence of the results from HT22 cells and from HT22-CRHR1 cells displaced with CP-376395, as they systematically show a greater association than random simulations. If we assume that ABP-09 and CRHR1 are not associated to an appreciable extent in these experiments, the difference can be reasonably interpreted by assuming that the available space for CRHR1 and ABP-09 location does not correspond to the whole cell volume, as used in the simulations. Under this interpretation, the available volume reduction results in a density increase that would shift horizontally (in Fig. 7C ) the lines corresponding to the experiments on HT22 cells and on HT22-CRHR1 cells displaced with CP-376395 with respect to the random simulations. If we perform this shift to make the curves coincide in Fig. 7C , a factor of two can be estimated in the density.
We consider the reported value of the dissociation constant of ABP-09-CRHR1 to be robust because: (i) the addition of CP-376395 as a displacement agent decreases the association, measured by the parameter Q ab , to levels similar to the ones in cells that lack the cMyc tag, and that can therefore be taken as a reference for unspecific association; (ii) as assessed by the molecular density in the field of view, concentrations lie in the mM range in the cell environment; (iii) we observe variations in the fraction of associated and free molecules as a function of local concentration in different cell portions within this mM range.
Conclusions
The molecular design strategy used here, which combined molecular docking and photochemical stability criteria, proved successful in producing a fluorescent marker for the antagonist site of CRHR1. ABP-09, an aza-BODIPY, shows excellent emission properties for stochastic single molecule-based fluorescence nanoscopy. Structural information for other members of class B GPCRs is currently growing. Thus, the strategy described in this work for the design of fluorescent probes based on known crystallographic structures anticipates a great impact in labeling experiments. In a wider sense, small molecule markers for proteins are suitable for tracking experiments in live cells, tissues, and even in whole organisms because this rationale avoids in vitro fusion protein production. In addition, we have developed an analysis method that is broadly applicable, to estimate association constants from high resolution localization microscopy images in cells.
Experimental section

Computational chemistry
All simulations were based on the crystal structure of class B GPCR CRHR1. 3 The molecular system was described in the dihedral space using the ECEPP/3 force field 67,68 within the ICM program 36,37 and prepared in a similar fashion as in earlier works. [69] [70] [71] Docking was performed within the orthosteric binding site after deleting all water molecules and co-factors, using a flexible-ligand-rigid-receptor approach as implemented in ICM. In the docking algorithm, the torsional degrees of freedom (DOF) of the small molecules and their six rigid coordinates were considered flexible within the receptor energy field, and subjected to a Monte Carlo global energy minimization. For the lowest docking energy pose of each molecule, an empirical docking score was calculated according to its fit within the binding site. 72 To improve convergence of the global energy minimization step, docking was performed twice and the lowest score per molecule was kept. Docked structures were refined in a ligand-steered fashion, where the molecules' DOF and receptor side chains within 6.0 Å were optimized using an energy minimization protocol (for a detailed description, cf. ref. 41, 43 and 73) .
Synthesis of ABP-09. The synthetic procedures and characterization of ABP-09 and intermediate compounds 1, 2, and 3 ( Fig. 3) are described in the ESI. † The synthesis was adapted from reported procedures. Characterization of the final product and reaction intermediates was achieved by combination of analytical, spectroscopic, and spectrometric procedures ( Fig. S1-S7 , ESI †). Spectral characterization of ABP-09 was carried out by absorption spectroscopy, and steady state and time resolved fluorescence spectroscopy, as detailed in the ESI. † ABP-09 uptake in live cells. HT22-CRHR1 cells were incubated in phenol red-free DMEM low glucose (Invitrogen) supplemented with 20 mM HEPES, 26 mM NaHCO 3 and 10 nM or 100 nM ABP-09. Fluorophore uptake kinetics in live cells was measured for 24 h using widefield fluorescence microscopy. Cell imaging conditions and fluorescence quantification protocols are described in the ESI. † In Fig. S12 (ESI †) , the temporal evolution of emission arising from live cells is shown. From these experiments, we selected a 20 h preincubation time for ABP-09 when used in cells.
Spectral FRET and imaging of cAMP. HT22-CRHR1-Epac-S H187 cells were preincubated as described for HT22-CRHR1 cells in the ABP-09 uptake experiments. To study the effect of CP-376395 (3212, TOCRIS), preincubation was carried out in either 10 or 100 nM concentrations of this compound. For the control cells, DMSO (vehicle) was used in the 20 h preincubation event. FRET experiments were carried out as previously described. 56 The acquisition conditions, image processing protocols and the characteristics of the fluorescence microscope are reported in detail in the ESI. † Briefly, HT22-CRHR1-EPAC-S H187 cells were seeded in glass-bottom dishes, grown, and incubated with ABP-09, CP-376395 or DMSO, as previously described. After preincubation, cells were stimulated with 10 nM human/rat CRH (H-2435, Bachem) at time 0. Movies were recorded acquiring images every 15 s, from t = À2 min until t = 15 min, at the spectral channels corresponding to the FRET pair (mTurquoise2 and Venus) and to ABP-09.
Super-resolution fluorescence microscopy (STORM). For STORM microscopy, HT22-CRHR1 and HT22 cells were preincubated for 20 h in phenol red-free DMEM low glucose (Invitrogen) supplemented with 20 mM HEPES, 26 mM NaHCO 3 and 10 nM ABP-09. For the antagonist displacement analysis, after the preincubation with ABP-09, cells were incubated for 15 min with 10 mM or 100 mM CP-376395. Fixation, the immunolabeling protocol and coverslip cleaning are described in detail in the ESI. † The STORM microscope was custom-built around an Olympus IX-73 inverted microscope operating in wide-field epifluorescence mode (Fig. S8, ESI †) . Two color images were acquired with an oil immersion objective Olympus PlanApo 60Â NA 1.42. Total internal reflection illumination mode (TIRF) was enabled by moving a linear stage (Thorlabs) so that the focus of the lasers translated laterally within the back focal plane of the objective. Fluorescent emissions from different species were separated with a dichroic mirror (Chroma ZT647rdc) and imaged onto adjacent areas of the EMCCD camera (Andor iXon3 897). The camera and lasers were controlled with custom software developed in the laboratory and described in an earlier publication. 74 A more extensive description of the microscope components can be found in the ESI † and Fig. S8 . The calibration protocol to find the affine transformation matrix for optimally overlapping the two emission channels is also presented in the ESI. † STORM data acquisition was carried out under laser intensities of 5-10 kW cm À2 for excitation, thus inducing an on-off switching of the fluorescent markers in the tens of ms time range, as required by the STORM technique. A Pre-Amp Gain of 5.1 and an EM Gain of 40 were used in the CCD camera. Throughout the whole acquisition, the activation 405 nm laser power was increased in steps whenever the density of single-molecule events decreased below B1 molecule per mm 2 . Typically, it took 20 000 frames of 30 ms of exposition time for each STORM acquisition. The previously found affine transformation was then applied to the raw images. Subsequent data analysis and the rendering of the final super-resolved image were performed with ThunderSTORM software 75 and finally the two color images were assembled with ImageJ/Fiji. 76 Estimation of the CRHR1-ABP-09 binding constant. STORM images were processed with a 13.3 nm pixel size to locate the molecules. For the assessment of association, a 9 pixel pattern was considered: the pixel where the central molecule was located and the 8 surrounding ones. Single molecule locations in a reconstructed STORM image were analyzed with custom MATLAB routines to count molecular pairs and isolated molecules. In this way, Q ij values were computed. To translate them into K ij values, simulated distributions for the random case and for different sets of values of K ij as a function of molecular density were used to calculate the ratio Q ab /Q ab,rndm in each case (Fig. S15 for the simulations and Fig. S17 for HT22-CRHR1 cells, ESI †). The density-averaged value of R ab = log(Q ab / Q ab,rndm ) was plotted as a function of input values of K ij (Fig. S16 , ESI †) to render the final calibration from which the association constants can be estimated.
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